Newsroom

Sorted by: Latest

-

Lumentum Appoints Thad Trent to Board of Directors

SAN JOSE, Calif.--(BUSINESS WIRE)--Lumentum Holdings Inc. ("Lumentum"), a global leader in optical and photonic technology, today announced the appointment of Thad Trent to the company's Board of Directors, effective immediately. His appointment expands the board membership to nine members. “I am thrilled to welcome Thad to the Lumentum Board,” said Penelope Herscher, Chair of Lumentum’s Board of Directors. “He brings a wealth of expertise in corporate finance, M&A activity, in-house manufa...
-

Voya Global Advantage and Premium Opportunity Fund & Voya Infrastructure, Industrials and Materials Fund Announces Payment of Monthly Distribution

SCOTTSDALE, Ariz.--(BUSINESS WIRE)--Voya Global Advantage and Premium Opportunity Fund (NYSE: IGA) and Voya Infrastructure, Industrials and Materials Fund (NYSE: IDE) (the “Funds”) today announced important information concerning the Funds’ distributions declared in November 2025. This press release is issued as required by the Funds’ Managed Distribution Plan (the “Plan") and an exemptive order received from the U.S. Securities and Exchange Commission. The Board of Trustees has approved the im...
-

InvenTrust Properties Corp. Declares Fourth Quarter 2025 Cash Dividend

DOWNERS GROVE, III.--(BUSINESS WIRE)--InvenTrust Properties Corp. (NYSE: IVT) announced today that its Board of Directors declared a fourth quarter 2025 cash distribution of $0.2377 per share of common stock. When annualized, this is equal to a rate of $0.9508 per share. This distribution will be paid on or about January 15, 2026, to stockholders of record as of December 30, 2025. About InvenTrust Properties Corp. InvenTrust Properties Corp. (the “Company,” "IVT," or "InvenTrust") is a premier...
-

Verastem Oncology Announces Strategic Transition Plan to Accelerate Next Phase of Growth

BOSTON--(BUSINESS WIRE)--Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with RAS/MAPK pathway-driven cancers, today announced strategic leadership changes to accelerate its next phase of growth. Michael Kauffman, M.D., Ph.D., currently lead director of the Board, has been appointed as the president of development and will join the Company’s executive leadership team, while John Johnson, a board member since 2020, has been appointe...
-

ICE Recycling Rebrands as Vaiire

LAKE CITY, S.C.--(BUSINESS WIRE)--ICE Recycling rebrands to Vaiire to reflect its expanded polymer solutions and materials services capabilities....
-

MindMed Announces New Employee Inducement Grant

NEW YORK--(BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company developing novel product candidates to treat brain health disorders, today announced the issuance of inducement grants to two newly hired non-executive employees consisting of options to purchase an aggregate of 31,500 common shares of the Company (the "Options") with an effective grant date of December 15, 2025. The Options have an exercise price...
-

Sleep Number Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

MINNEAPOLIS--(BUSINESS WIRE)--Sleep Number Corporation (Nasdaq: SNBR) today announced that it granted an equity award on December 15, 2025, as a material inducement to the employment of the company's newly-hired Executive Vice President and Chief Financial Officer, Amy O’Keefe. As previously disclosed, in connection with the appointment of O’Keefe as Executive Vice President and Chief Financial Officer effective December 8, 2025, Sleep Number granted O’Keefe an employment inducement award consi...
-

Immunome Announces Proposed Public Offering of Common Stock

BOTHELL, Wash.--(BUSINESS WIRE)--Immunome, Inc. (“Immunome”) (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer therapies, today announced its plans to commence an underwritten public offering, subject to market and other conditions, to issue and sell $400 million of shares of its common stock. All of the shares are being offered by Immunome. In connection with the proposed offering, Immunome expects to grant the underwriters a 30-day...
-

Computerworld Names Five9 to 2026 List of Best Places to Work in IT

SAN RAMON, Calif.--(BUSINESS WIRE)--Five9 (Nasdaq: FIVN), provider of the Intelligent CX Platform, today announced that it has been named to Foundry’s Computerworld 2026 Best Places to Work in IT list for the third consecutive year, recognizing the company as one of the top organizations that challenge their IT staff while providing great benefits and compensation. This year, Five9 achieved several notable placements, including: #12 Overall for Midsize Companies, up from #13 in 2025 #7 for Work...
-

Letitia Quinones-Hollins Earns Recognition in The Best Lawyers in America Guide for 2026

HOUSTON--(BUSINESS WIRE)--Quinones & Associates, PLLC is pleased to announce that founder Letitia Quinones-Hollins has been recognized in The Best Lawyers in America guide, a listing of the nation’s top attorneys, for 2026. The respected legal guide for a third consecutive year selected Ms. Quinones-Hollins for expertise in general and white-collar criminal defense work. “This honor is especially rewarding in that it comes from the lawyers who do this kind of work every single day,” said Ms...